Header Logo

Connection

KENNETH MCCLAIN to Melphalan

Back to Details
This is a "connection" page, showing publications KENNETH MCCLAIN has written about Melphalan.
KENNETH MCCLAIN
Connection Strength
0.050
Melphalan
  1. Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT. Blood Adv. 2023 07 25; 7(14):3725-3734.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.